Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

CHEN Yao, SONG Xiangqing. Meropenem regimens based on the simple mathematical model of T>MIC for two-compartment model[J]. Journal of Pharmaceutical Practice and Service, 2017, 35(4): 341-345. doi: 10.3969/j.issn.1006-0111.2017.04.013
Citation: CHEN Yao, SONG Xiangqing. Meropenem regimens based on the simple mathematical model of T>MIC for two-compartment model[J]. Journal of Pharmaceutical Practice and Service, 2017, 35(4): 341-345. doi: 10.3969/j.issn.1006-0111.2017.04.013

Meropenem regimens based on the simple mathematical model of T>MIC for two-compartment model

doi: 10.3969/j.issn.1006-0111.2017.04.013
  • Received Date: 2016-09-17
  • Rev Recd Date: 2017-01-16
  • Objective To simplify the calculation of T>MIC and evaluate meropenem regimens based on the simple mathematical model of T>MIC reported in literature for two-compartment model. Methods Six meropenem regimens were designed according to the recommended dose with the infusion duration of 0.5 h and 3 h. Four different MIC susceptibility breakpoint of meropenem against clinical microbiologic flora were used to formulate different T>MIC.Each T>MIC was calculated by both the simple and two-compartment model of T>MIC.Meropenem regimens were evaluated for different bacterial infections based on the simple model of T>MIC with 40%~100% of the T>MIC% as the target. The t-test suggested no significant difference between the pairs of T>MIC calculated by the two models. Results and Conclusion Simple model of T>MIC can replace the two-compartment model.Meropenem regimens can be optimized based on this simple model of T>MIC conveniently and quickly.
  • [1] Lee LS,Kinzig-Schippers M,Nafziger AN,et al.Comparison of 30min and 3h infusion regimens for imipenem/cilastatin and for meropenem evaluated by Monte Carlo simulation [J].Diagn Microbiol Infect Dis,2010,68(3):251-258.
    [2] Peric M,Browne FA,Jacobs MR,et al.Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections:Use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents[J].Clin Ther,2003,25(1):169-177.
    [3] 李小芳,宋香清.哌拉西林他唑巴坦抗铜绿假单胞菌感染的T>MIC%的推导及在方案评价与优化中的作用[J].中国药师,2015,18(7):1086-1091.
    [4] 宋香清,龙明辉,杨立平.基于T>MIC简易数学模型的哌拉西林他唑巴坦给药方案设计与优化[J].中国医院药学杂志,2016,36(11):911-916.
    [5] 宋香清,龙明辉,杨立平,等.颅脑外科手术患者术中预防使用抗菌药物追加时机与次数研究[J].中华医院感染学杂志,2016,26(18):4151-4154.
    [6] Clinical and Laboratory Standards Institute.Performance Standards for Antimicrobial Susceptibility Testing:Twenty-second Informational Supplement M100-S26[S].USA,2016:52-112.
    [7] 杨 阳,李 昕,王 林,等.基于PK/PD参数的碳青霉烯类药物给药方案设计[J].中南药学,2013,11(2):157-159.
    [8] Iakovlev SV,Beloborodov VB,Sidorenko SV,et al.Multi-centre study of comparative efficacy of meropenem and combined regimens for empirical antibacterial therapy of severe nosocomial infections:Results of clinical and pharmacoeconomic analysis[J].Antibiot Chemother,2006,51(7):15-27.
    [9] Koomanachai P,Bulik CC,Kuti JL,et al.Pharmacodynamic modeling of intravenous antibiotics against gram-negative bacteria collected in the United States[J].Clin Ther,2010,32(4):766-779.
    [10] Li C,Du X,Kuti JL,et al.Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections[J].Antimicrob Agents Chemother,2007,51(5):1725-1730.
    [11] McKinnon PS,Paladino JA,Schentag JJ.Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections[J].Int J Antimicrob Agents,2008,31(4):345-351.
    [12] Zhou QT,He B,Zhang C,et al.Pharmacokinetics and pharmacodynamics of meropenem in elderly Chinese with lower respiratory tract infections:Population pharmacokinetics analysis using nonlinear mixed-effects modelling and clinical pharmacodynamics study[J].Drugs Aging,2011,28(11):903-912.
    [13] Fraenkel CJ,UllbergM,Bernander S,et al.In vitro activities of three carbapenems against recent bacterial isolates from severely ill patients at Swedish hospitals[J].Scand J Infect Dis,2006,38(10):853-859.
  • 加载中
通讯作者: 陈斌, [email protected]
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(2981) PDF downloads(504) Cited by()

Related
Proportional views

Meropenem regimens based on the simple mathematical model of T>MIC for two-compartment model

doi: 10.3969/j.issn.1006-0111.2017.04.013

Abstract: Objective To simplify the calculation of T>MIC and evaluate meropenem regimens based on the simple mathematical model of T>MIC reported in literature for two-compartment model. Methods Six meropenem regimens were designed according to the recommended dose with the infusion duration of 0.5 h and 3 h. Four different MIC susceptibility breakpoint of meropenem against clinical microbiologic flora were used to formulate different T>MIC.Each T>MIC was calculated by both the simple and two-compartment model of T>MIC.Meropenem regimens were evaluated for different bacterial infections based on the simple model of T>MIC with 40%~100% of the T>MIC% as the target. The t-test suggested no significant difference between the pairs of T>MIC calculated by the two models. Results and Conclusion Simple model of T>MIC can replace the two-compartment model.Meropenem regimens can be optimized based on this simple model of T>MIC conveniently and quickly.

CHEN Yao, SONG Xiangqing. Meropenem regimens based on the simple mathematical model of T>MIC for two-compartment model[J]. Journal of Pharmaceutical Practice and Service, 2017, 35(4): 341-345. doi: 10.3969/j.issn.1006-0111.2017.04.013
Citation: CHEN Yao, SONG Xiangqing. Meropenem regimens based on the simple mathematical model of T>MIC for two-compartment model[J]. Journal of Pharmaceutical Practice and Service, 2017, 35(4): 341-345. doi: 10.3969/j.issn.1006-0111.2017.04.013
Reference (13)

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return